Taiwan FDA registration 603c03a00a9eb7edc3e3e4f9f4889f19
IMAT's blood glucose test tablets
TW: 宜瑪氏血糖測試片
Taiwan·Risk Class 2·EPS BIO TECHNOLOGY CORP.·Registered Nov 22, 2022 – Nov 22, 2027ActiveRegistration details
- Analysis ID
- 603c03a00a9eb7edc3e3e4f9f4889f19
Company information
- Manufacturer
- EPS BIO TECHNOLOGY CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- EPS BIO TECHNOLOGY CORP.
Product details
- Intended Use
- It is suitable for in vitro measurement of glucose content in fresh microvascular whole blood samples, and can be used with Fuyong Ilimax, IMA Professional and IMA Smart blood glucose machines, not suitable for newborn detection.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Nov 22, 2022
- Expiry Date
- Nov 22, 2027
About this record
Access comprehensive regulatory information for IMAT's blood glucose test tablets in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 603c03a00a9eb7edc3e3e4f9f4889f19 and manufactured by EPS BIO TECHNOLOGY CORP.. The authorized representative in Taiwan is EPS BIO TECHNOLOGY CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices